IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $775,000 | +40.9% | 16,700 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $550,000 | -40.0% | 16,700 | -50.0% | 0.00% | 0.0% |
| Q2 2020 | $916,000 | -63.7% | 33,400 | -60.3% | 0.00% | -66.7% |
| Q1 2020 | $2,520,000 | +232.0% | 84,200 | -1.9% | 0.01% | +100.0% |
| Q4 2018 | $759,000 | -34.6% | 85,795 | -16.9% | 0.00% | -25.0% |
| Q3 2018 | $1,161,000 | -12.1% | 103,195 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $1,321,000 | -7.7% | 103,195 | +21.8% | 0.01% | -16.7% |
| Q1 2018 | $1,431,000 | -73.3% | 84,703 | -87.3% | 0.01% | -71.4% |
| Q4 2017 | $5,352,000 | +3.1% | 668,975 | -0.1% | 0.02% | -4.5% |
| Q3 2017 | $5,189,000 | +4.0% | 669,587 | -1.4% | 0.02% | -4.3% |
| Q2 2017 | $4,989,000 | – | 678,767 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |